Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sachin Pai
Corcept Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 02
Scottsdale, Arizona, United States
Recruiting - Site 04
Los Angeles, California, United States
Recruiting - Site 12
Orange, California, United States
Recruiting - Site 06
Atlanta, Georgia, United States
Recruiting - Site 14
Goshen, Indiana, United States
Recruiting - Site 03
Grand Rapids, Michigan, United States
Recruiting - Site 10
East Brunswick, New Jersey, United States
Recruiting - Site 11
Morristown, New Jersey, United States
Recruiting - Site 08
Albany, New York, United States
Recruiting - Site 05
Lake Success, New York, United States
Withdrawn - Site 07
Shirley, New York, United States
Recruiting - Site 13
Cincinnati, Ohio, United States
Recruiting - Site 09
Nashville, Tennessee, United States
Recruiting - Site 01
San Antonio, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jan 2026
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 80
- Registry id
- NCT07259317
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.